Who should prescribe weight loss drugs? IFSO says doctors’ competence, not speciality, should decide

The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has issued a statement arguing that obesity medication prescribing rights should be based on physician competence rather than medical specialty. The group suggests that current restrictions in countries like India limit patient access and fragment care.
Why it matters
This debate highlights the tension between regulatory safety measures and the need for broader access to increasingly popular weight-loss drugs like GLP-1 agonists.
Synopsis: A position statement by the International Federation for the Surgery of Obesity and Metabolic Disorders says doctors should be allowed to prescribe obesity medications based on their training and competence, not speciality. It identifies India among countries with speciality-based restrictions and calls for trained bariatric surgeons and other physicians to be recognised as eligible prescribers under defined competency standards.
Doctors should be allowed to prescribe obesity management medications based on their training and competence, rather than their medical speciality, the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has said in a new position statement.
The statement, published in The Lancet Diabetes and Endocrinology on 30 October, argues that restricting prescribing rights to specific specialities could delay treatment, limit geographical access and fragment care for people living with obesity.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in